68
Hangzhou Biotest Biotech Co.,Ltd.
688767.SS · SHH
¥38.31 -1.62% (-¥0.63)
1M +0.26%
Market Cap ¥5.81B
P/E Ratio 325.69x
Div. Yield -
ROE 0.77%
Bulios Fair Price
¥29.3
23.5% downside
Current Price
¥38.31
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 688767.SS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
11 /100
Expensive P/B 2.71x
P/S 12.64x
P/E 325.69x
Growth
2 /100
Declining Rev. growth 38.22%
Book val. growth 2.56%
EPS growth 60.47%
Profitability
33 /100
Weak FCF margin 15.40%
Op. margin 4.98%
Gross margin 98.97%
Quality
5 /100
Poor Asset turnover 0.19x
ROA 0.74%
ROIC 1.07%
Debt
100 /100
Low Current ratio 9.51x
Net debt/EBITDA -21.98x
Debt/Equity 0.05x
Stability
40 /100
Moderate Profitable years 6
EPS volatility 81.83%
Beta 0.66x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 688767.SS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Shujiang Wu
Employees
613
Headquarters
Hangzhou